Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dimitrios Arkilo
Observed name:
D. Arkilo
Observed institutions:
Tufts University,
Tufts Medical Center,
United Hospital,
Tufts Children's Hospital,
Minnesota Epilepsy Group,
Sage Therapeutics (United States),
Children's Minnesota,
Takeda (United States),
Takeda (Japan)
show all 9
ORCID:
0000-0002-7487-2747
Observed ORCID:
0000-0002-7487-2747
OpenAlex ID:
A5079209617
A phase 2, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox–Gastaut syndrome ( ELEKTRA )
2022
·
Cecil D. Hahn
, Yuwu Jiang
, et al.
·
Epilepsia
·
81
PDF
A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies
2021
·
Jonathan J. Halford
, Michael R. Sperling
, et al.
·
Epilepsy Research
·
51
PDF
Emergency Department Use of Neuroimaging in Children and Adolescents Presenting with Headache
2018
·
Meghan R. Cain
, Dimitrios Arkilo
, et al.
·
The Journal of Pediatrics
·
44
Clinical experience of intravenous lacosamide in infants and young children
2016
·
Dimitrios Arkilo
, Mary Gustafson
, et al.
·
European Journal of Paediatric Neurology
·
37
15q Duplication Syndrome and Related Disorders
2016
·
Brenda Finucane
, Laina Lusk
, et al.
·
Europe PMC (PubMed Central)
·
35
Safety, pharmacokinetics and pharmacodynamics of TAK‐418, a novel inhibitor of the epigenetic modulator lysine‐specific demethylase 1A
2021
·
Wei Yin
, Dimitrios Arkilo
, et al.
·
British Journal of Clinical Pharmacology
·
29
PDF
Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE)
2023
·
Scott Demarest
, Shafali Jeste
, et al.
·
Epilepsy & Behavior
·
24
Electroencephalographic patterns during sleep in children with chromosome 15q11.2-13.1 duplications (Dup15q)
2016
·
Dimitrios Arkilo
, Orrin Devinsky
, et al.
·
Epilepsy & Behavior
·
20
PDF
In Vitro Metabolism of Slowly Cleared G Protein–Coupled Receptor 139 Agonist TAK-041 Using Rat, Dog, Monkey, and Human Hepatocyte Models (HepatoPac): Correlation with In Vivo Metabolism
2020
·
Amin Kamel
, Steve Bowlin
, et al.
·
Drug Metabolism and Disposition
·
17
PDF
Pregnancy and neurodevelopmental outcomes with in-utero antiepileptic agent exposure. A pilot study
2014
·
Dimitrios Arkilo
, Julie Hanna
, et al.
·
European Journal of Paediatric Neurology
·
16
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of TAK‐041 in healthy participants and patients with stable schizophrenia
2022
·
Wei Yin
, David Han
, et al.
·
British Journal of Clinical Pharmacology
·
15
PDF
Time interval required for return to baseline of the background rhythm on electroencephalogram after recorded electrographic seizures
2013
·
Dimitrios Arkilo
, Sonya Wang
, et al.
·
Epilepsy Research
·
15
Ketogenic diet: Predictors of seizure control
2017
·
Nitin Agarwal
, Dimitrios Arkilo
, et al.
·
SAGE Open Medicine
·
14
Multisite Semiautomated Clinical Data Repository for Duplication 15q Syndrome: Study Protocol and Early Uses
2017
·
Oluwaseun Jessica Ajayi
, Ebony Jeannae Smith
, et al.
·
JMIR Research Protocols
·
13
PDF
Diverse Seizure Presentation of Acute Mycoplasma Pneumoniae Encephalitis Resolving With Immunotherapy
2013
·
Dimitrios Arkilo
, Beth Pierce
, et al.
·
Journal of Child Neurology
·
10
Efficacy, Safety and Tolerability of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Pediatric Patients with Dravet Syndrome and Lennox-Gastaut Syndrome (ELEKTRA) (4234)
2021
·
Cecil D. Hahn
, Yuwu Jiang
, et al.
·
Neurology
·
9
A Randomized Phase 2 KINETIC Trial Evaluating SAGE ‐324/ BIIB124 in Individuals with Essential Tremor
2024
·
Rodger J. Elble
, William G. Ondo
, et al.
·
Movement Disorders
·
7
PDF
A Potential Role for Felbamate in TSC- and NF1-Related Epilepsy: A Case Report and Review of the Literature
2015
·
Natanya M. Mishal
, Dimitrios Arkilo
, et al.
·
Case Reports in Neurological Medicine
·
7
PDF
Randomized controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in adults with complex regional pain syndrome
2022
·
Stuart Ratcliffe
, Dimitrios Arkilo
, et al.
·
Pain Medicine
·
6
PDF
Initial Data From the Ongoing ENDYMION Open-label Extension Trial of Soticlestat (TAK-935/OV935) in Participants With Developmental and/or Epileptic Encephalopathies (DEE) (4492)
2020
·
Jonathan Halford
, Dimitrios Arkilo
, et al.
·
Neurology
·
4
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
2025
·
Peter C. T. Hawkins
, Adam J. Schwarz
, et al.
·
Psychopharmacology
·
3
PDF
Efficacy, Safety and Tolerability of Soticlestat (TAK-935/OV935) as an Adjunctive Therapy in Patients with 15q Duplication Syndrome (Dup15q) or Cyclin-Dependent Kinase-Like 5 Deficiency Disorder (CDD) in a Signal-Finding Phase 2 Study (ARCADE) (4096)
2021
·
Scott Demarest
, Shafali Jeste
, et al.
·
Neurology
·
2
A Phase 1b/2a Study of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Adults With Developmental and/or Epileptic Encephalopathies (DEE) (4715)
2020
·
Jonathan Halford
, Michael Sperling
, et al.
·
Neurology
·
2
Antiepileptic drug use during pregnancy: sodium valproate is associated with lower offspring IQ
2015
·
Dimitrios Arkilo
, Eleni Okeanis Vaou
·
Evidence-Based Nursing
·
2
Long-Term Soticlestat Treatment in Patients with Developmental and/or Epileptic Encephalopathies in the ENDYMION Ongoing Open-Label Extension Study (4197)
2021
·
Cecil D. Hahn
, Yuwa Jiang
, et al.
·
Neurology
·
1
Show more works
View as search
Works count:
39
Citation count:
466
H-index:
13
I10-index:
15
Year
Topic
Type
